Detalles de la búsqueda
1.
Tumour-draining axillary lymph nodes in patients with large and locally advanced breast cancers undergoing neoadjuvant chemotherapy (NAC): the crucial contribution of immune cells (effector, regulatory) and cytokines (Th1, Th2) to immune-mediated tumour cell death induced by NAC.
BMC Cancer
; 18(1): 123, 2018 02 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29390966
2.
Natural killer (NK) cell profiles in blood and tumour in women with large and locally advanced breast cancer (LLABC) and their contribution to a pathological complete response (PCR) in the tumour following neoadjuvant chemotherapy (NAC): differential restoration of blood profiles by NAC and surgery.
J Transl Med
; 13: 180, 2015 Jun 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-26040463
3.
A phase 1 trial of human telomerase reverse transcriptase (hTERT) vaccination combined with therapeutic strategies to control immune-suppressor mechanisms.
Exp Biol Med (Maywood)
; 249: 10021, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38463391
4.
Abnormal T regulatory cells (Tregs: FOXP3+, CTLA-4+), myeloid-derived suppressor cells (MDSCs: monocytic, granulocytic) and polarised T helper cell profiles (Th1, Th2, Th17) in women with large and locally advanced breast cancers undergoing neoadjuvant chemotherapy (NAC) and surgery: failure of abolition of abnormal treg profile with treatment and correlation of treg levels with pathological response to NAC.
J Transl Med
; 11: 16, 2013 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23320561
5.
The stem cell factor antibody enhances the chemotherapeutic effect of adriamycin on chemoresistant breast cancer cells.
Cancer Cell Int
; 12(1): 21, 2012 05 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-22642642
6.
Effects on quality of life, anti-cancer responses, breast conserving surgery and survival with neoadjuvant docetaxel: a randomised study of sequential weekly versus three-weekly docetaxel following neoadjuvant doxorubicin and cyclophosphamide in women with primary breast cancer.
BMC Cancer
; 11: 179, 2011 May 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-21592370
7.
Generation in vivo of peptide-specific cytotoxic T cells and presence of regulatory T cells during vaccination with hTERT (class I and II) peptide-pulsed DCs.
J Transl Med
; 7: 18, 2009 Mar 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-19298672
8.
Management of the axilla in women with breast cancer: current clinical practice and a new selective targeted approach.
Ann Surg Oncol
; 15(5): 1282-96, 2008 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-18330650
9.
Retraction: The stem cell factor antibody enhances the chemotherapeutic effect of adriamycin on chemoresistant breast cancer cells.
Cancer Cell Int
; 13(1): 96, 2013 Oct 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-24228731
10.
Predicting response to neoadjuvant chemotherapy in breast cancer: molecular imaging, systemic biomarkers and the cancer metabolome (Review).
Oncol Rep
; 20(4): 699-703, 2008 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-18813806
11.
18F-FDG dual-headed gamma camera PET in detection of axillary nodal disease in patients with large or locally advanced breast cancer: possible alternative staging of axilla.
Oncol Rep
; 18(6): 1545-9, 2007 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-17982642
12.
The Differential Contribution of the Innate Immune System to a Good Pathological Response in the Breast and Axillary Lymph Nodes Induced by Neoadjuvant Chemotherapy in Women with Large and Locally Advanced Breast Cancers.
J Immunol Res
; 2017: 1049023, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28913366
13.
Crucial Contributions by T Lymphocytes (Effector, Regulatory, and Checkpoint Inhibitor) and Cytokines (TH1, TH2, and TH17) to a Pathological Complete Response Induced by Neoadjuvant Chemotherapy in Women with Breast Cancer.
J Immunol Res
; 2016: 4757405, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27777963
14.
Monitoring the response of large (>3 cm) and locally advanced (T3-4, N0-2) breast cancer to neoadjuvant chemotherapy using (99m)Tc-Sestamibi uptake.
Nucl Med Commun
; 26(1): 9-15, 2005 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-15604942
15.
Women with large (≥3 cm) and locally advanced breast cancers (T3, 4, N1, 2, M0) receiving neoadjuvant chemotherapy (NAC: cyclophosphamide, doxorubicin, docetaxel): addition of capecitabine improves 4-year disease-free survival.
Springerplus
; 4: 9, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25995984
16.
A comparison of 18F-FDG gamma camera PET, mammography and ultrasonography in demonstrating primary disease in locally advanced breast cancer.
Nucl Med Commun
; 25(7): 721-5, 2004 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-15208500
17.
Breast cancer chemoresistance: emerging importance of cancer stem cells.
Surg Oncol
; 19(1): 27-32, 2010 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19251410
18.
Annexins in human breast cancer: Possible predictors of pathological response to neoadjuvant chemotherapy.
Eur J Cancer
; 45(7): 1274-1281, 2009 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19171478
Resultados
1 -
18
de 18
1
Próxima >
>>